Svetlana Staykova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Svetlana Staykova has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Dancho Danalev
Department of Organic Chemistry, University of Chemical Technology and Metallurgy, Blvd. 8 Kl. Ohridski, 1756, Sofia, Bulgaria
1 shared publication- Diana Wesselinova
Institute of General and Comparative Pathology, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, Bl. 25, 1113, Sofia, Bulgaria
1 shared publication - Emilia Naydenova
Department of Organic Chemistry, University of Chemical Technology and Metallurgy, 1797 Sofia, Bulgaria
1 shared publication - Tatyana Dzimbova
Department Sport, Faculty of Public Health, Health Care and Sport, South-West University “Neofit Rilski”, 2700 Blagoevgrad, Bulgaria
1 shared publication
Latest Publications
- 26 July 2019
- Published by Springer Nature in Amino Acids
- Vol. 51 (9) , 1247-1257
Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids
Somatostatin (SST) is an endogenous cyclic tetradecapeptide hormone that exerts multiple biological activities via a family of five receptors. BIM-23052 (DC-23-99) d-Phe-Phe-Phe-d-Trp-Lys-Thr-Phe-Thr-NH2 is a linear SST analog with established in vitro GH-inhibitory activity and high affinity to sstr5, sstr3 and sstr2. The different SSTR subtypes are expressed in different tissues and in some tumor cells. Based on this finding, a series of new analogs of BIM-23052 with expected antitumor activity have been synthesized. The Thr at position 6 in BIM-23052 was replaced by the conformationally hindered Tle, Aib, Ac5c and Ac6c of the new analogs. The peptides were synthesized by standard solid-phase peptide chemistry methods, Fmoc strategy. The cytotoxic effects of the compounds were tested in vitro against a panel of tumor cell lines: HT-29, MDA-MB-23, Hep-G2, HeLa and the normal human diploid cell line Lep-3. All five somatostatin receptor subtypes were modeled and docking was performed to determine the binding affinity of the analogs. The new peptides exhibited different concentration-dependent antiproliferative effect on the tumor cell lines after 24 h of treatment. The compound 3B (Aib6) demonstrated the most pronounced antiproliferative effects on HepG-2 cells with the IC50 = 0.01349 nM. Docking confirmed that all compounds bind well to SST receptors with preference to sstr3 and sstr5, which is most probably the reason for the observed biological effects.
- 26 July 2019
- Published by Springer Nature in Amino Acids
- Vol. 51 (9) , 1247-1257
Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids
Somatostatin (SST) is an endogenous cyclic tetradecapeptide hormone that exerts multiple biological activities via a family of five receptors. BIM-23052 (DC-23-99) d-Phe-Phe-Phe-d-Trp-Lys-Thr-Phe-Thr-NH2 is a linear SST analog with established in vitro GH-inhibitory activity and high affinity to sstr5, sstr3 and sstr2. The different SSTR subtypes are expressed in different tissues and in some tumor cells. Based on this finding, a series of new analogs of BIM-23052 with expected antitumor activity have been synthesized. The Thr at position 6 in BIM-23052 was replaced by the conformationally hindered Tle, Aib, Ac5c and Ac6c of the new analogs. The peptides were synthesized by standard solid-phase peptide chemistry methods, Fmoc strategy. The cytotoxic effects of the compounds were tested in vitro against a panel of tumor cell lines: HT-29, MDA-MB-23, Hep-G2, HeLa and the normal human diploid cell line Lep-3. All five somatostatin receptor subtypes were modeled and docking was performed to determine the binding affinity of the analogs. The new peptides exhibited different concentration-dependent antiproliferative effect on the tumor cell lines after 24 h of treatment. The compound 3B (Aib6) demonstrated the most pronounced antiproliferative effects on HepG-2 cells with the IC50 = 0.01349 nM. Docking confirmed that all compounds bind well to SST receptors with preference to sstr3 and sstr5, which is most probably the reason for the observed biological effects.